Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion type Assertion NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_head.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion description "[Given previous evidence of Layer II/III and V pyramidal cell alterations in schizophrenia and the significant influence of subunit composition on NMDA and AMPA receptor function, laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion evidence source_evidence_literature NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion SIO_000772 17942280 NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion wasDerivedFrom befree-20150227 NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.
- NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_assertion wasGeneratedBy ECO_0000203 NP434444.RA9GfTKcotw53nWOcf8BuBmjfWw_FbiXUEmzwEf2DtLVY130_provenance.